UK may allow certain devices to bypass cost:benefit analysis in future - update
This article was originally published in RAJ Devices
The Department of Health in England will consider extending its “innovation pass” scheme to medical devices “at an appropriate time in the future”1,2. The scheme is currently applicable only to promising new medicines and will be piloted in April3.
You may also be interested in...
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.